Markets

Alkermes (ALKS) Stock Price Target Raised to $53 by Mizuho

Published on 4/10/2026

#ALKS#Mizuho#stock price target
Alkermes (ALKS) Stock Price Target Raised to $53 by Mizuho

AI Summary

Summarized by AI from the source below

Mizuho increased its price target for Alkermes (ALKS) to $53, attributing the change to improved confidence in the company's drug pipeline. This revision reflects optimism regarding potential therapeutic advancements. The adjustment is significant for investors monitoring ALKS, as price targets can influence market sentiment and trading decisions. Increased confidence in drug development may correlate with higher stock valuations moving forward.

Share:
Source: Read original article (opens in new tab)

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Related News

TSX AI Stocks Show Market Quality Signals for Investors
Markets

TSX AI Stocks Show Market Quality Signals for Investors

Jul 9

TSX Penny Stocks See Increased Attention Amid Market Changes
Markets

TSX Penny Stocks See Increased Attention Amid Market Changes

Jul 9

Invesco QQQ Trust (QQQ) sees $24M Options Trade Highlights
Markets

Invesco QQQ Trust (QQQ) sees $24M Options Trade Highlights

Jul 9

S&P/TSX Composite Rises Over 200 Points Increasing Investor Optimism
Markets

S&P/TSX Composite Rises Over 200 Points Increasing Investor Optimism

Jul 9